Fisher Wallace Laboratories, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Fisher Wallace Laboratories, Inc. - overview
Established
2007
Location
New York, NY-New York, US
Primary Industry
Medical Devices & Equipment
About
Founded in 2007 and based in New York, US, Fisher Wallace Laboratories, Inc. operates as a manufacturing company that provides wearable medical devices for the treatment of depression, anxiety, and insomnia and helps to manage sleeping patterns and reduce stress. In March 2022, Fisher Wallace Laboratories, Inc. raised USD 2.
5 million in venture funding led by SHUFL Capital. The company's device Fisher Wallace Stimulator® increases neurochemical production and lowers cortisol levels and stimulates the brain's electrical system to provide rapid symptom relief and improved cognitive function. The company plans to use the venture funding to accelerate its growth strategy which includes more research and development of Version 2. 0 products, including the company's first mobile app.
Current Investors
SHUFL Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.fisherwallace.com
Verticals
Manufacturing, Wearables & Quantified Self
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Fisher Wallace Laboratories, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.